tm logo
ALLUMINOX
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 08 Apr 2024

Last Applicant/ Owned by

11080 Roselle St.

San Diego

CA

92121

Serial Number

97065108 filed on 08th Oct 2021

Registration Number

N/A

Correspondent Address

Gina Durham, Esq.

DLA Piper LLP US

555 Mission Street, Suite 2400

San Francisco,CA 94105-2933

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ALLUMINOX

Scientific, biological, and medical research; conducting clinical trials for others for the purpose of advancing knowledge and developing new approaches; providing prescription scientific drug research information by means of providing links to third party websites relating to cancer drugs; Providing temporary use of on-line non-downloadable software for tracking and storing personal information aRead More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Providing medical information in the field of health care, medical conditions, medicine and pharmaceuticals; Providing medical information on pharmaceuticals and oncology platforms; Providing medical and patient support information in relation to the treatment of cancer; counseling services, namely, medical counseling for patients diagnosed with cancer related to prevention and treatment; information services in the field of treating cancer; Providing online information services, namely, prescription drug medical information; Providing information in the field of medicine; providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; Providing an Internet website featuring information and content about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing an online searchable database featuring articles and information about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing healthcare information regarding cancer drugs and cancer treatment; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing

Class [042]
Computer & Software Services & Scientific Services


Scientific, biological, and medical research; conducting clinical trials for others for the purpose of advancing knowledge and developing new approaches; providing prescription scientific drug research information by means of providing links to third party websites relating to cancer drugs; Providing temporary use of on-line non-downloadable software for tracking and storing personal information about the symptoms, side effects, treatment of and experience with an individual's cancer, logging daily actions and results of activity and cognitive tests, and sharing results based on such information; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing

Class [041]
Education and Entertainment Services


Educational services, namely, providing classes, seminars, and lectures, all in the field of treatment of cancer; providing training in the oncology field; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing

Mark Details


Serial Number

No 97065108

Mark Type

No Service Mark

Attorney Docket Number

No 428927-129

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08th Apr 2024SOU TEAS EXTENSION RECEIVED
08th Apr 2024SOU EXTENSION 3 FILED
08th Apr 2024SOU EXTENSION 3 GRANTED
26th Oct 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24th Oct 2023SOU TEAS EXTENSION RECEIVED
24th Oct 2023SOU EXTENSION 2 FILED
24th Oct 2023SOU EXTENSION 2 GRANTED
13th Apr 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11th Apr 2023SOU TEAS EXTENSION RECEIVED